chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pharmacist who injected him put the needle in very deep, deeper than I've seen on any of the other vaccinations my son has had.  It looked like the needle could almost reach the bone.  When he removed the needle there was a lot of blood, which I also have never seen happen with my son before on any vaccination he has received since birth (he has received all of them and is up to date).  The pharmacist did not ask us to wait for 15 minutes after the injection, so we left the pharmacy area immediately to go into the shopping area of local store. My son is normally ok with getting vaccines and doesn't get too scared or upset.  This time, however, he seemed to go into a little bit of shock soon afterwards.  He was pale and upset and he said that he didn't feel good and felt like he wanted to throw up.  He didn't throw up, however and seemed to recover after a little while and with some distraction looking at toys.  That evening his arm was sore and he had a raised, hard bruise at the injection site a little larger than a pea.  It felt like a bubble of blood under the skin.  Then, the next morning, he vomited once after eating vitamin gummies.  He hadn't had any other food yet.  He appeared pale.  About 30-40 minutes later we gave him dry toast to eat.  It has now been 45 min. from the event and he seems ok so far.
On 10/16/2001 vaccine given, originally no reaction noted. On 10/17/2001 about 1/2 inch localized pink area with edema and slightly warm to touch. Warm compress applied.
Injection site soreness, diffuse muscle aches, fatigue, fever (102 degrees) - occurred on first day post vaccination, extending into second day post vaccination - largely resolved with Advil. Did not have symptoms except injection site soreness with the first in the series of this vaccine.
Very Noticeable Swollen right eye area, cheek, and nose with very itchy eyes.   Left side is  less puffy.
Patient was seen on 03/05/2020 to be evaluated for rash and nonspecific skin eruption.  This has been a problem for the past 2 weeks.  The rash has not occurred previously.  It is located primarily over the abdominal region and on the left are and right arm/  He describes rash as flesh-colored and bumpy.  The rash is itch.  Associated symptoms include itch.  Possible contributing factors include vaccination on 02/19/2020.
Neck movement was severely limited about a month after 2nd dose; couldn't even climb out of bed! After Physical Therapy (and Yoga), neck rotation on axis is around 90% of pre-vaccine rotation range/limit.  I have not had prior neck rotation/movement issues.
Mild headache that started 1 hour post injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 28-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ADDERALL; PROZAC. Vaccination history included: Covid-19 vaccine (Primary immunization completed, Manufacturer: Unknown), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Mild headache that started 1 hour post injection".  Additional Information: Mild headache that started 1 hour post injection. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
At Day 8, injection site was red (about 2 inch diameter), slightly swollen and warm. 48 hours later, the redness and swelling had decreased by half. After 72 hours, the area was almost back to normal skin color and no longer swollen or warm.
Pt received vax on 1/31/00. Has lesions on back, breast, leg. 1 vesicular looking in hairline others scabbed over. Pt has been scratching areas. 1 lesion is infected (had pus and redness).
Palpations below left peck by sternum, Chest pain below left peck and moves around up towards left clavicle, Tired feels like I am carrying a heavy bag on my back.  Just started Indomethacin on 10/13/2021.
neurological issues; Arm pain; Joint pain throughout body; night tremors, similar to GBS but not GBS; This case was reported by a other health professional via sales rep and described the occurrence of neurological disorder nos in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced neurological disorder nos, pain in arm, joint pain and tremor. On an unknown date, the outcome of the neurological disorder nos, pain in arm, joint pain and tremor were recovered/resolved.   It was unknown if the reporter considered the neurological disorder nos, pain in arm, joint pain and tremor to be related to Shingrix.  Additional details were reported as follows: The reporter was an office manager. The age at vaccination was not reported. The reporter stated that the patient received Shingrix vaccine and experienced neurological issues, arm pain, by evening joint pain throughout the body and that night tremors, similar to GBS (Guillain-Barre syndrome) but not diagnosed as GBS,  issues continued for 6 weeks reported to pharmacy and was advised to not get 2nd dose. The reporter agreed to follow-up from GlaxoSmithKline.
Flu; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via social media.  This case involves a female patient (age unspecified) who had a flu (Influenza), when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date (20 years ago), the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Arm was hurting; not feeling well,; Nausea; red spot vaccination site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting), VACCINATION COMPLICATION (not feeling well,), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (red spot vaccination site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting), VACCINATION COMPLICATION (not feeling well,), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (red spot vaccination site).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
pt recvd vax;c/o "not feeling well" on 29oct;Lt upper arm swollen approx 4-5 cm in diam on 31oct;red, warm to touch;pt feeling better but lt arm still very sore;
Information has been received from a nurse immunization coordinator concerning a patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On an unspecified date the patient had a severe case of shingles that involved a lesion on the optic nerve. There was no information regarding patient history of chickenpox or varicella virus vaccine live (Oka/Merck) immunization. The patient sough unspecified medical attention. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Follow-up information was received on 11-DEC-2007 indicating the patient did not receive the second dose of varicella virus vaccine live (Oka/Merck). "Concern raised because increase in shingles since beginning routine of second dose of varicella virus vaccine live (Oka/Merck)." This is one of several reports received from the same source. Additional information has been requested.
Initial information received on 18-Mar-2019 regarding an unsolicited valid non-serious case received from a nurse by phone. This case involves patient of unknown demographics where something happened a while ago and got it, while received vaccine ACT-HIB. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE (lot number: UI764AA, expiry date, dose, dose in series, route and site of administration were not reported). On an unknown date, something happened a while ago and a patient got it (unevaluable event) following the administration of HIB (PRP/T) VACCINE. No Lab data was reported. Final diagnosis was something happened a while ago and a patient got it. It was not reported if the patient received a corrective treatment. The event outcome was reported as Unknown for something happened a while ago and a patient got it. Documents held by the sender: none.
Several hours after getting out of bed the day after receiving the Pfizer booster I started experiencing body aches, followed by light-headedness and eventual passing out for a few moments.  I then experienced some vomiting of breakfast I had eaten.  I became extremely weak, and a headache and severe body aches persisted for approximately the next 8-9 hours.  I did sleep well that night, however, and the next day these symptoms were gone.
3 hrs after I came down with a fever of 100, and body chills. By 2am I had busy aches.  Fatigue and really low energy started that following week. By the end of that week, I was feeling like a truck hit me. As of Monday April 5, I couldn't work. Dizziness and light headedness began. I want getting any better. Better vaccine I felt amazing, but I started to feel like death. I called my primary Dr first who ran bloodwork, then Dr took over from there.  The vaccine dumped my TSH levels fast, I had hit 30 and with having a total Thyroidectomy my levels need to be about 167 for me to feel my best. I've been stable for quite some time. I have had a drop before in the past but never felt so lathargic and sick as I have this time. I'm returning to work finally Monday May 3. It's been a long haul , getting better, and honestly I was scared to get the vaccine not knowing how my system would react due to having autoimmune diseases. I guess I found out the hard way.
Headache. Started about two hours after vaccine. Has not subsided in 24hrs I took Tylenol 500ml two tablets, twice and today I took Aleve two tablets My left deltoid is warm & inflamed started 1/5/21 sometime in the evening
I continue to experience angioedema, i.e. itching and especially swelling of the feet (most common), hands, lips, buttocks, even my testicles and penis once, on an ongoing basis.  These swellings happen serially, i.e. not all at once, with intermission periods in-between of up to a week, but usually only a day or two.  The swellings typically end within 24 hrs.
Typical side effects at first  but intermittent headaches and low fever lasted for over a week. Major depressive episode triggered by vaccine and still persisting.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient received a first dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) recomb. vaccine (manufacturer unknown) (dose, route and site of administration, lot# and expiration date were unknown). On 20-JUN-2016, the patient received the second dose of GARDASIL intramuscularly , lot # M014929, expiration date: 27-MAY-2017 and inadvertently on 29-JUN-2016, the patient received the third dose of GARDASIL intramuscularly, lot # M014929, expiration date: 27-MAY-2017, which was outside of the prescribing information recommendation. There was no adverse effects reported. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of ROTATEQ, orally (dose, dose number and lot# not reported). On an unknown date, 5 days after the vaccination the patient was hospitalized with the diagnosis of gastritis. The outcome of event was unknown. The causality was not reported. Additional information has been requested.
difficulty swallowing; difficulty breathing; urticaria/Hives; This spontaneous case was reported by a patient and describes the occurrence of DYSPHAGIA (difficulty swallowing), DYSPNOEA (difficulty breathing) and URTICARIA (urticaria/Hives) in a 45-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 011H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 microgram. On 13-Dec-2022, the patient experienced DYSPHAGIA (difficulty swallowing), DYSPNOEA (difficulty breathing) and URTICARIA (urticaria/Hives). The patient was treated with PREDNISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DYSPHAGIA (difficulty swallowing), DYSPNOEA (difficulty breathing) and URTICARIA (urticaria/Hives) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  It was reported that patient had urticaria full body reaction 1 week post injection. Hives are dermographic and has caused in the beginning difficulty swallowing and breathing. Patient had to use an inhaler for a week every morning.  Patient was treated with prednisone and antihistamines as well as topicals. no relief and is still present as of 2/10/23. It is unknown if the patient experienced any additional symptoms/events.
Information has been received from a physician concerning a 50 day old male patient with no medical history and no drug reactions or allergies who on 18-FEB-2010, was vaccinated with the first dose of "regular dose" of ROTATEQ orally (lot # 664876/1470Y). On the same day, the patient also received a dose of PENTACEL, PREVNAR and ENGERIX B (manufacturer unknown). On 18-FEB-2010 the patient experienced diarrhea, lethargy, vomiting green, pale and not responsive. The interval between the administration of ROTATEQ and the onset of symptoms was not provided. The patient went to emergency room. No lab diagnostics studies were performed. On 19-FEB-2010, the patient recovered. Follow up information was received from the physician which reported that the male patient on 18-FEB-2010, was vaccinated with the first PO dose of ROTATEQ orally (lot # 664876/1470Y). On the same day, the patient also received the first dose of PENTACEL (lot # C3497AA) in the right vastus lateralis, the first dose of PREVNAR (lot # E13862) into left vastus lateralis and the first dose of ENGERIX B (lot # AHBUB818AA) in left vastus lateralis. On 18-FEB-2010, the patient experienced severe vomiting and diarrhea. Subsequently the patient recovered. The patient did not seek medical attention. Additional information is not expected.
Bruising; Swelling; Soreness / Pain; Enduration hardness about size of 2 inches by 2 inches; This case was reported by a nurse via call center representative and described the occurrence of contusion in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABX747AA, expiry date 28th February 2020) for prophylaxis.   On 6th May 2019, the patient received Bexsero (intramuscular) .5 ml. On 6th May 2019, less than a day after receiving Bexsero, the patient experienced contusion, swelling, pain and induration. On an unknown date, the outcome of the contusion, swelling, pain and induration were not recovered/not resolved.   It was unknown if the reporter considered the contusion, swelling, pain and induration to be related to Bexsero.  Additional case details were reported as follows: The patient received vaccine in left arm. On the day of vaccination patient experienced bruising, swelling, soreness, pain and enduration hardness about size of 2 inches by 2 inches. The patient still experiencing all the side effects. The reporter reporting adverse events for two patients. This case had been linked to the case US2019086305, reported by same reporter.
Patient had a vasovagal episode post vaccination @ 15:16. Patient appeared lightheaded, dizzy, Sweating. Patient was by herself   Patient was instructed to lay down and elevate her legs patient was given  Water Outcome:Recovered at 15:35 patient educated about ER precaution, signs of vasovagal reactions and what to do if exhibit symptoms again . Patient acknowledged understanding. Patient left after being observed for extra 15 minutes.  Vital Signs: @ 15:16 Blood Pressure: 122/79 Pulse: 69 O2: 98% room air  Vital Signs: @ 15:25 Blood Pressure: 125/85 Pulse: 66 O2: 98%   Vital Signs: @ 15:30 Blood Pressure: 121/81 Pulse: 68 O2: 98%
Information has been received concerning a pt who was vaccinated with varicella vaccine on 03/06/00. On 06/19/00 the pt presented with a case of chickenpox described as spotty all over. 2 or 3 blistered lesions, and afebrile. There was no known exposure to wild type varicella.
Patient received GARDASIL #1. Left office with no complaints. Mom called back 1 hour later saying she was having chest pain and anxiety. Spoke to Dr. who told her to give MAALOX and if no better in 15 minutes to go to ER. Went to ER given EKG and chest x-ray all normal. Patient discharged.
Headache almost quickly after injection. Some tingling of tongue and lips within 30-60 min lasting for about an hour.
fatigue; Pain in  injection site; headache; diaphoretic; nauseous; felt like I was gong to pass out; dry heaves; ringing in my ears; vision changes; unwellness; This is a spontaneous report from a Non-contactable nurse, the patient. A 33 (units unknown) adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date 11:15 as a single dose for Covid-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced pain in injection site which began later in the evening, a little soreness only and a little bit of a headache; and fatigue and feeling unwell. The next morning the patient experienced feeling diaphoretic, nauseous, felt like she was going to pass out, vision changes, ringing in ears and dry heaves. It was reported she was doing every she could do to keep consciousness and did not feel better until she had the dry heaves. The clinical outcome of the events visual changes, ringing in the ears and dry heaves was recovered; fatigue and unwellness was not recovered; vaccination site pain, headache, diaphoretic, nauseous, and dizziness was unknown.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Pt called to report that she was given the Pfizer Bivalent vaccine on 5/9/2023 and days later she developed hives/rash over her chest, sides, and both arms. She has been taking Benadryl and using calamine lotion. Pt reports the rash is getting better but she may go to an urgent care to have it looked at. She was informed this would be the best option as she does not have a primary care physician. She was asked to bring any records to department so they can be added to her chart for future vaccine considerations.
She felt shortness of breath; feeling sore and weak; pain in her L arm (from where se received the injection of PNEUMOVAX 23 the day before); feeling sore and weak; the swelling was not only around the injection site, but also in her L armpit; PNEUMOVAX 23 was inadvertently administered to a patient on 26-JUL-2022 after it was improperly stored; This spontaneous report was received from a licensed practical nurse and refers to a 73-year-old female patient. The patient's medical history included right cataract. The patient's concurrent conditions included asthma, depression, iron deficiency anaemia, heart murmur, tobacco use and shortness of breath (dyspnea on exertion). Concomitant medications included dextran (reported also as artificial tears), famotidine (PEPCID), iron supplement, salbutamol (ALBUTEROL) inhaler, formoterol fumarate (+) mometasone furoate (DULERA) inhaler and loratadine (CLARITINE).   On 26-JUL-2022, the patient was inadvertently vaccinated with improperly stored (product storage error) dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, 0.5 milliliter, administered in her left arm, lot #: W004863 upon internal validation was confirmed as valid, expiration date: 21-AUG-2023 (strength and route of administration were not provided) for prevention of pneumococcal disease. Temperature excursion information: 8.7 degree Celsius for 15 minutes. No previous temperature excursion.   On 27-JUL-2022, the patient felt shortness of breath, swelling and pain in her left arm from where she received the injection of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) the day before. The swelling was not only around the injection site but also in her left armpit. On the same day, the patient was feeling sore and weak. The reporter recommended the patient to go to emergency room but the patient declined and the reporter was unaware of the patient receiving or seeking any medical treatment. On 28-JUL-2022, the reporter followed up again with the patient and she reported that the swelling had improved. Outcome of the rest of events was not provided.   The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
Small knot at injection site. Varue soreness in (R) deltoid muscle area. Redness to knot.
pt recv vax 1PM 21SEP96 & later had an eye exam & went home;about 4PM took a nap;around 5PM woke up lt ear was ringing loudly about 6PM pt daughter called & pt stated could not hear at all from left ear;
Right upper arm swollen, indurated, painful, erythematous within 24 hours of immunizations. No fever, limited ROM, swelling, redness and erythema, extended from antesubterol to above shoulder joint. Treated with Augmentin for a presumed cellulitis and Benadryl.
got my first shot yesterday and am experiencing chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (got my first shot yesterday and am experiencing chest pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced CHEST PAIN (got my first shot yesterday and am experiencing chest pain). At the time of the report, CHEST PAIN (got my first shot yesterday and am experiencing chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
Rash and swelling throughout body. States rash lasted approximately one week. Swelling in ankles still not resolved.